HomeCompareCDC vs JNJ

CDC vs JNJ: Dividend Comparison 2026

CDC yields 3.19% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CDC wins by $4.5K in total portfolio value
10 years
CDC
CDC
● Live price
3.19%
Share price
$71.43
Annual div
$2.28
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.6K
Annual income
$392.27
Full CDC calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — CDC vs JNJ

📍 CDC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCDCJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CDC + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CDC pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CDC
Annual income on $10K today (after 15% tax)
$271.45/yr
After 10yr DRIP, annual income (after tax)
$333.43/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $370.18/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CDC + JNJ for your $10,000?

CDC: 50%JNJ: 50%
100% JNJ50/50100% CDC
Portfolio after 10yr
$22.3K
Annual income
$610.02/yr
Blended yield
2.74%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CDC
No analyst data
Price Target
$57.00
-20.2% upside vs current
Range: $57.00 — $57.00
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CDC buys
0
JNJ buys
0
No recent congressional trades found for CDC or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCDCJNJ
Forward yield3.19%3.36%
Annual dividend / share$2.28$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$24.6K$20.0K
Annual income after 10y$392.27$827.78
Total dividends collected$3.6K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst price target$57.00$228.73

Year-by-year: CDC vs JNJ ($10,000, DRIP)

YearCDC PortfolioCDC Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,019$319.36$10,676$355.77+$343.00CDC
2$12,120$328.89$11,407$389.39+$713.00CDC
3$13,306$338.06$12,198$426.53+$1.1KCDC
4$14,584$346.88$13,056$467.62+$1.5KCDC
5$15,961$355.33$13,987$513.12+$2.0KCDC
6$17,441$363.42$14,998$563.56+$2.4KCDC
7$19,033$371.15$16,098$619.52+$2.9KCDC
8$20,744$378.53$17,295$681.69+$3.4KCDC
9$22,582$385.57$18,599$750.82+$4.0KCDC
10$24,555$392.27$20,022$827.78+$4.5KCDC

CDC vs JNJ: Complete Analysis 2026

CDCStock

The VictoryShares US EQ Income Enhanced Volatility Wtd ETF seeks to provide investment results that track the performance of the Nasdaq Victory US Large Cap High Dividend 100 Long/Cash Volatility Weighted Index (the Long/Cash Index) before fees and expenses. Volatility Weighting Methodology Combines fundamental criteria and volatility weighting in an effort to outperform traditional cap-weighted indexing strategies. About the Long/Cash Index The Long/Cash Index tactically reduces its exposure to the equity markets during periods of significant market declines and reinvests when market prices have further declined or rebounded. The Nasdaq Victory US Large Cap High Dividend 100 Long/Cash Volatility Weighted Index is based on the month-end price of the Nasdaq Victory US Large Cap High Dividend 100 Volatility Weighted Index (the “Reference Index”). The exit and reinvestment methodology of the Long/Cash Index is based on the month-end value of the Reference Index relative to its All-Time Highest Daily Closing Value (“AHDCV”). AHDCV is the highest daily closing price the Reference Index has achieved since its inception date.

Full CDC Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this CDC vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CDC vs SCHDCDC vs JEPICDC vs OCDC vs KOCDC vs MAINCDC vs ABBVCDC vs MRKCDC vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.